Are we choosing the correct FSH starting dose during controlled ovarian stimulation for intrauterine insemination cycles? Potential application of a nomogram based on woman’s age and markers of ovarian reserve
- 21 September 2018
- journal article
- research article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 298 (5) , 1029-1035
Abstract
Purpose To evaluate the potential application of a nomogram based on woman’s age and ovarian reserve markers as a tool to optimize the follicle-stimulating hormone (FSH) starting dose in intrauterine insemination (IUI) cycles. Methods We conducted a retrospective analysis enrolling 179 infertile women undergoing controlled ovarian stimulation (COS), followed by IUI. Each woman received an FSH starting dose according to clinical decision. After collecting data about COS and IUI procedures, we calculated the FSH starting dose according to the nomogram. The main outcomes measured were women’s baseline characteristics, COS, and clinical outcomes. Results The FSH starting dose calculated by the nomogram was significantly lower than the one actually prescribed (p < 0.001), in only 14.8% of the cycles nomogram calculated a higher starting dose. When gonadotropin dose was decreased during COS, and similarly in case of hyper-response (more than two follicles ≥ 16 mm retrieved), the FSH starting dose calculated by the nomogram would have been lower in most of the cases (81.8% and 48.8%, respectively). Conversely, when gonadotropin dose was increased during COS and in case of low ovarian response (no follicle ≥ 16 mm retrieved), the FSH starting dose calculated by the nomogram would have been lower in most of the cases (64.7% and 100%, respectively); in these groups median anti-Müllerian hormone (AMH) level was 5.62 ng/mL. Conclusions The application of this nomogram in IUI cycles would lead to a more tailored FSH starting dose and improved cost-effectiveness, although in PCOS women, particularly the ones with high AMH, it does not seem adequate.Keywords
This publication has 37 references indexed in Scilit:
- Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI)Cochrane Database of Systematic Reviews, 2018
- Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE†Human Reproduction, 2017
- Intra-uterine insemination for unexplained subfertilityCochrane Database of Systematic Reviews, 2016
- Assisted reproductive technology: an overview of Cochrane ReviewsCochrane Database of Systematic Reviews, 2015
- Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSHReproductive BioMedicine Online, 2013
- Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practiceHuman Reproduction Update, 2013
- Comparison of different starting gonadotropin doses (50, 75 and 100 IU daily) for ovulation induction combined with intrauterine inseminationArchives of Gynecology and Obstetrics, 2012
- Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation inductionHuman Reproduction, 2010
- The influence of the number of follicles on pregnancy rates in intrauterine insemination with ovarian stimulation: a meta-analysisHuman Reproduction Update, 2008
- A systematic review of tests predicting ovarian reserve and IVF outcomeHuman Reproduction Update, 2006